脑脊液管理市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

脑脊液管理市场主要受到全球脑积水患病率上升和人口老龄化的推动。

根据国家脑积水基金会 2018 年关于脑积水的事实，脑积水是最常见的出生缺陷之一，每年每 500 名儿童中就有 1 名受到影响，每年还会增加 6,000 名儿童。出生两年后，他患上了脑积水. 此外，老年人脑积水的发病率也很高。 全球神经系统疾病负担的增加预计将推动市场增长。 此外，不断增加的研发和产品发布以及设备技术的进步正在推动市场的增长。 然而，意识低下、缺乏熟练的专业人员以及 FDA 最近的警告预计会阻碍市场增长。

脑脊液管理市场的趋势

分流器市场有望显着扩大

分流系统将多余的脑脊液从大脑排出到身体的其他部位，并在循环过程中被吸收。 脑脊液分流器包含三个主要组件：流入管（导管）、调节流体流动的阀门和将流体输送到腹部和心臟并在那里被吸收的流出导管。它由 3 个组件组成。

分流器相对于传统引流技术的优势，加上脑脊髓分流器技术的进步，预计将在预测期内推动细分市场的增长。 2017 年 11 月，Alcyone Lifesciences 获得美国食品和药物管理局批准用于治疗脑积水的 Alivio Ventricular Catheter & Flusher System（Alivio System）。

此外，由于人口老龄化带来的神经系统疾病负担增加，因此按患者类型划分，老年医学领域有望实现显着的市场增长。

北美有望实现显着增长

由于发达的医疗基础设施、对脑积水治疗方法的认识不断提高以及大公司的存在，预计北美将实现显着增长。 据脑积水协会估计，大约有 100 万美国人在其生命的各个阶段都患有脑积水。 据估计，美国每 770 个婴儿中就有 1 个会患上脑积水。 此外，由于对神经系统疾病和治疗的认识不断提高，以及脑积水的负担不断增加，预计亚太地区将经历利润丰厚的市场增长。

脑脊液管理市场竞争分析

全球脑脊液管理市场竞争适中。 市场参与者正专注于新产品发布、产品创新和地域扩张，以巩固其市场份额。 例如，Arkis BioSciences Inc. 的 Cerebroflo 脑室外引流 (EVD) 导管已获得 FDA 批准，这是第一个包含永久性聚合物添加剂 Endexo 的神经导管。 市场上的主要参与者包括 Medtronic Plc、B. Braun Melsungen AG、Integra Lifesciences (Arkis BioSciences)。

其他福利。

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 调查结果
• 调查假设
• 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动因素
  • 脑积水和其他神经系统疾病的负担增加
  • 微创手术的流行和老年人口的增加
• 市场製约因素
  • 缺乏熟练的专业人员
  • 与脑脊液管理系统相关的并发症
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 按产品分类
  • 调车
    • 通过阀门
    • 可调节分流阀
    • 单压力阀分流器
    • 按类型
    • 小静脉腹膜 (VP) 分流术
    • 心房 (VA) 分流术
    • 腰腹腔 (LP) 分流术
    • 静脉胸膜 (VPL) 分流
  • 体外血管引流装置
• 按地区细分
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • Medtronic Plc
  • B. Braun Melsungen AG
  • Integra Lifesciences（Arkis BioSciences）
  • Natus Medical Incorporated
  • Sophysa
  • Johnson & Johnson
  • Spiegelberg GmbH & Co. KG
  • Moeller Medica

第7章 市场机会今后动向

The cerebrospinal fluid management market is primarily driven by the growing hydrocephalus worldwide and the growing geriatric population. According to National Hydrocephalus Foundation, facts about hydrocephalus 2018, hydrocephalus is one of the most common birth defects and each year, one out of the 500 children suffers from hydrocephalus, and another 6000 children annually develop hydrocephalus during the first two years of the life. Moreover, the rate of hydrocephalus is also high in the older population. The growing burden of neurological disorders around the world is anticipated to boost the market growth. Moreover, the increasing R&D in advancements of device technologies coupled with the product launches are fueling the market growth. However, lack of awareness, the dearth of skilled professionals and recent warning letters from the FDA are anticipated to hinder the market growth.

Cerebrospinal Fluid Management Market Trends

Shunts are Expected to Have Significant Market Growth

These shunt systems remove excess cerebrospinal fluid from the brain to other parts of the body where the fluid is absorbed as part of the circulatory process. Cerebrospinal fluid shunts contain three main components i.e. an in-flow tube (catheter), a valve that regulates the flow of fluid, and an outflow catheter that carries the fluid to the abdomen or the heart where the fluid can be absorbed.

The advantages of shunts over the traditional drainage procedures coupled with the advancements in cerebrospinal shunt technologies are anticipated to boost the segment growth over the forecast period. In November 2017, Alcyone Lifesciences has received U.S. Food and Drug Administration approval for Alivio Ventricular Catheter & Flusher System (Alivio System) for the treatment of hydrocephalus.

Moreover, among the patient types, the geriatric segment anticipated having the notable market growth owing to the increasing burden of neurological disorders with an aging population.

North America is Anticipated to Have Significant Growth

Among the regions, North America is anticipated to grow at significant rates owing to the well-established healthcare infrastructure, growing awareness regarding the available options for treatment of hydrocephalus and the presence of key market players in the region. Hydrocephalus Association has estimated that around 1 million Americans are affected by hydrocephalus in every stage of life. Also, one out of the 770 babies in America, develops hydrocephalus. Moreover, Asia Pacific is anticipated to have the lucrative market growth owing to the growing awareness regarding the neurological disease and treatment options coupled with the growing burden of hydrocephalus in the region.

Cerebrospinal Fluid Management Market Competitive Analysis

The global cerebrospinal fluid management market is moderately competitive. Market players are focusing on new product launches, product innovations and geographical expansion to strengthen its market share. For instance, Arkis BioSciences Inc. has received FDA approval for its External Ventricular Drainage (EVD) Catheter, CerebroFlo, the first neuro catheter to incorporate Endexo, a permanent polymer additive. The key market players operating in the market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences (Arkis BioSciences),

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Hydrocephalus and Other Neurological Disorders
  • 4.2.2 Growing Adoption of Minimally Invasive Solutions and Rising Geriatric Population
• 4.3 Market Restraints
  • 4.3.1 Dearth of Skilled Professionals
  • 4.3.2 Complications Related to Cerebrospinal Fluid Management Systems
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Products
  • 5.1.1 Shunts
    • 5.1.1.1 By Valve
    • 5.1.1.1.1 Adjustable Valve Shunts
    • 5.1.1.1.2 Monopressure Valve Shunts
    • 5.1.1.2 By Type
    • 5.1.1.2.1 Ventriculoperitoneal (VP) Shunts
    • 5.1.1.2.2 Ventriculoatrial (VA) Shunts
    • 5.1.1.2.3 Lumboperitoneal (LP) Shunts
    • 5.1.1.2.4 Ventriculopleural (VPL) Shunts
  • 5.1.2 ExternaL Vascular Drainage Devices
• 5.2 By Geography
  • 5.2.1 North America
    • 5.2.1.1 United States
    • 5.2.1.2 Canada
    • 5.2.1.3 Mexico
  • 5.2.2 Europe
    • 5.2.2.1 Germany
    • 5.2.2.2 United Kingdom
    • 5.2.2.3 France
    • 5.2.2.4 Italy
    • 5.2.2.5 Spain
    • 5.2.2.6 Rest of Europe
  • 5.2.3 Asia-Pacific
    • 5.2.3.1 China
    • 5.2.3.2 Japan
    • 5.2.3.3 India
    • 5.2.3.4 Australia
    • 5.2.3.5 South Korea
    • 5.2.3.6 Rest of Asia-Pacific
  • 5.2.4 Middle-East and Africa
    • 5.2.4.1 GCC
    • 5.2.4.2 South Africa
    • 5.2.4.3 Rest of Middle-East and Africa
  • 5.2.5 South America
    • 5.2.5.1 Brazil
    • 5.2.5.2 Argentina
    • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Medtronic Plc
  • 6.1.2 B. Braun Melsungen AG
  • 6.1.3 Integra Lifesciences (Arkis BioSciences)
  • 6.1.4 Natus Medical Incorporated
  • 6.1.5 Sophysa
  • 6.1.6 Johnson & Johnson
  • 6.1.7 Spiegelberg GmbH & Co. KG
  • 6.1.8 Moeller Medica

7 MARKET OPPORTUNITIES AND FUTURE TRENDS